HSPA4L Antilichaam - middengebied: FITC (ARP53692 P050-FITC)

Heat shock 70kDa protein 4-like

APG1, APG-1, HSPH3, Osp94

22824

O95757

NP_055093

Human, Mouse, Rat, Dog, Horse, Pig

The immunogen is a synthetic peptide directed towards the middle region of human HSPA4L

HSPA4L possesses chaperone activity in vitro where it inhibits aggregation of citrate synthase.

SUMO2; STUB1; TTC1; SGTA; HSPA8; HSF1; UBC; IPO7; SEC23A; RANBP3; STAT1; PPP2R2A; GARS; APEH; PUS7; LUC7L2; METTL21A; PAXIP1; DIAPH1; NUP188; NUBP2; VPS26A; TERF2; PHLDA1; TUSC2; TCEAL1; DOK2; USF2; KRT8

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

HSPA4L is supported by BioGPS gene expression data to be expressed in COLO205

0.5 mg/ml

Dog: 93%; Horse: 93%; Human: 100%; Mouse: 90%; Pig: 79%; Rat: 90%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

92kDa

Ewing, R.M., Mol. Syst. Biol. 3, 89 (2007)

Wet Ice

839

HSPA4L

HSPA4L

Rabbit

Heat shock 70 kDa protein 4L

NM_014278

KCHAEHTPEEEIDHTGAKTKSAVSDKQDRLNQTLKKGKVKSIDLPIQSSL